Case Summary (G.R. No. 229956)
The Letter of Intent: substantive clauses at issue
The LOI contained: (1) a non‑compete provision (Section 4) obliging MDI and MMC to channel all CT and MRI work to CII and restraining Dr. Adapon from competing in those fields; and (2) Section 11, an arbitration clause stating that disputes arising out of the LOI or if parties could not agree on details should be submitted to a three‑arbitrator panel, with the parties to “abide by the ruling” and maintain status quo pending arbitration. The parties continued to conduct business consistent with the LOI until MDI’s later acquisitions raised complaints of breach.
Procedural steps: referral to arbitration and arbitral proceedings
After petitioners’ 2011 complaint and denial of injunctive relief by the RTC, the RTC suspended proceedings and ordered arbitration under the LOI (consistent with the competence‑competence and stay provisions). The parties proceeded to arbitration under jointly signed Terms of Reference before the three‑member tribunal. Both sides submitted pleadings, evidence and memorials. The arbitral panel issued a Final Award on May 8, 2015.
Arbitral tribunal’s findings and reliefs awarded
The arbitral tribunal (majority) found jurisdiction to hear the dispute based on the LOI and applicable arbitration statutes and rules. Substantively, it concluded that: (a) the LOI’s non‑compete provision was binding and enforceable; (b) MDI violated the non‑compete in 1997/1998, 2011 and 2012 when it installed and used imaging equipment for paying patients; (c) prescription barred claims for damages from 1998 to 2009 but not for violations after 2009; (d) the non‑compete was not an unreasonable restraint of trade; (e) petitioner Dr. Adapon’s personal claims were cognizable notwithstanding the derivative nature of parts of the suit; and (f) the doctrine of rebus sic stantibus did not apply. The tribunal awarded PhP 71,349,157.45 actual and compensatory damages to Dr. Adapon; PhP 5,000,000 moral damages; PhP 2,000,000 exemplary damages; PhP 9,000,000 attorney’s fees; dismissed MDI’s counterclaims; and allocated costs per the Philippine Dispute Resolution Center rules.
Dissenting arbitrator’s view and respondent’s petition to vacate
Arbitrator Dante O. Tinga dissented, arguing among other points that: (1) the RTC lacked jurisdiction over Dr. Adapon’s personal claims because the action was derivative and the cause of action belonged to CII; (2) the LOI and non‑compete were not binding; (3) prescription barred the claims; (4) enforcement would be an unreasonable restraint on trade; (5) application of rebus sic stantibus was warranted given alleged catastrophic effects on MMC’s residency program; and (6) the damages award lacked adequate factual and legal basis. MDI thereafter filed a petition to vacate the arbitral award in the RTC, relying primarily on grounds that the tribunal exceeded its powers (including contesting the LOI’s binding effect, prescription, rebus sic stantibus, clean hands, and the basis for damages), and alleging evident partiality in respect of an expert witness’s participation.
RTC confirmation of the award
The Regional Trial Court (as special commercial court) confirmed the Final Award (Feb. 19, 2016), holding that (1) the LOI was a valid and enforceable agreement; (2) MDI failed to establish any grounds under Rule 11.4 of the Special ADR Rules to vacate the award; and (3) the award’s damages determinations involved factual findings and law interpretation that the court could not disturb under the Special ADR Rules. A motion for reconsideration was denied (June 21, 2016).
Court of Appeals reversal and bases for vacation
On appeal the Court of Appeals reversed and vacated the Final Award (Feb. 15, 2017). The CA reasoned that (1) the LOI was merely a preliminary expression of intent and not a binding contract, therefore there was no binding arbitration agreement; (2) prescription had run on the causes of action since the first alleged breach occurred in 1998 and the complaint was filed in 2011; (3) the RTC, as a special commercial court, lacked jurisdiction because the action was an ordinary civil breach of contract action rather than an intra‑corporate controversy; and (4) the arbitral tribunal exceeded its authority in awarding damages to Dr. Adapon personally despite an allegedly non‑existent contract and asserted lack of personal cause of action.
Issues presented to the Supreme Court
The Supreme Court was called upon to determine whether the Court of Appeals properly vacated the arbitral Final Award based on: (1) the LOI’s legal effect and whether the arbitration agreement was binding and enforceable; (2) prescription of the causes of action; (3) jurisdiction of the RTC and propriety of its referral to arbitration; and (4) the arbitral tribunal’s authority to award damages in the circumstances, including personal claims by Dr. Adapon in a derivative context.
Governing standards for judicial review of arbitral awards
The decision reiterates the pro‑arbitration policy: party autonomy, competence‑competence (tribunal’s primary opportunity to rule on jurisdiction), and judicial restraint under the Special ADR Rules and the Arbitration Law. Rule 11.4 of the Special ADR Rules (drawing on Sections 24–25 of RA 876) enumerates exclusive and limited grounds to vacate an award (e.g., corruption, evident partiality, misconduct, disqualification not disclosed, exceeding powers, non‑existence/invalidity of arbitration agreement). Rule 11.9, Rule 19.7 and Rule 19.10 emphasize that courts shall not disturb arbitral findings of fact or law, that awards are final and binding, and that vacatur is limited to the specific statutory grounds. The Model Law provisions incorporated by the ADR Act also provide the similar limited grounds for setting aside an award.
Analysis and ruling on the arbitration agreement and competence to arbitrate
The Supreme Court held that the Court of Appeals erred in finding no binding arbitration agreement. Key points: (a) MDI did not raise the issue of invalidity/enforceability of the arbitration clause in its petition to vacate at the RTC in a manner that warranted disturbing the tribunal’s decision; (b) Section 11 of the LOI contained a broad arbitration agreement to resolve “any matter arising out of this Letter of Intent” and to “abide by the ruling” of the tribunal; (c) separability doctrine applies — an arbitration clause is independent of the rest of the contract and remains enforceable even if other provisions are incomplete or the main contract is challenged; (d) given the tribunal’s jurisdictional determination, the Court of Appeals should not have substituted its own interpretation of the LOI for that of the arbitral tribunal, because Rules 11.9 and 19.10 preclude review on merits or interpretation of law/fact absent the enumerated statutory grounds. Accordingly, the arbitral tribunal’s determination of its competence and the LOI’s enforceability should not have been disturbed.
Analysis and ruling on prescription
On prescription, the arbitral tribunal applied equitable principles and the “continuing violation” approach: while damage claims rooted in the 1998 breach were time‑barred, subsequent breaches (from 2009 onward, when petitioners learned of renewed or continuing violations) gave rise to fresh causes of action within the ten‑year prescriptive period under Article 1144. The Supreme Court found no egregious error in the tribunal’s application of law and equity that would fall within the limited statutory grounds for vacatur; disputes over prescription implicated factual determinations and equitable judgments that courts should not substitute for the tribunal’s assessments absent the statutory grounds. Thus the CA’s substitution of its own assessment on prescription was improper.
Analysis and ruling on jurisdiction of the RTC and referral to arbitration
The Supreme Court rejected the CA’s
...continue readingCase Syllabus (G.R. No. 229956)
Procedural Posture
- Petition for Review filed in the Supreme Court under Rule 19.36 of the Special Rules on Alternative Dispute Resolution (Special ADR Rules) challenging the Court of Appeals Decision dated February 15, 2017 (CA-G.R. SP No. 146577) that reversed the Regional Trial Court (RTC) Resolution confirming an arbitral Final Award dated May 8, 2015.
- Underlying case began with a Complaint filed by Dr. Benjamin D. Adapon on April 25, 2011 for himself and as minority shareholder of Computerized Imaging Institute, Inc. (CII), alleging breach of a non-compete clause in a Letter of Intent against Medical Doctors, Inc. (MDI).
- RTC (Special Commercial Court, Branch 149, Makati) denied a temporary restraining order, suspended proceedings, and ordered arbitration pursuant to Section 11 of the Letter of Intent; later confirmed the arbitral Final Award in a Resolution dated February 19, 2016 and denied reconsideration on June 21, 2016.
- MDI filed a Petition to Vacate the arbitral award before the RTC and later sought relief in the Court of Appeals; the Court of Appeals vacated the arbitral Final Award and reversed the RTC’s confirmation in its February 15, 2017 Decision.
- Petitioners appealed to the Supreme Court, which granted the Petition, reversed the Court of Appeals, and reinstated the RTC Resolution confirming the Final Award.
Factual Background
- Dr. Benjamin D. Adapon was a medical expert in neuroradiology, computed tomography, diagnostic and therapeutic neuroangiography; Medical Doctors, Inc. owns and operates Makati Medical Center (MMC).
- In the late 1970s, Drs. Constantino P. Manahan, Raul G. Fores and Romeo H. Gustillo (incorporators/directors/principal doctors of Medical Doctors) invited Dr. Adapon to set up and head a computed tomography facility for MMC.
- On February 15, 1978, Computed Tomography Center, Inc. (CTCI), later renamed Computerized Imaging Institute, Inc. (CII), was incorporated: MDI held 60% of outstanding capital stock; Dr. Adapon and nominees held 40%; Dr. Adapon served as CII president and ran the tomography operations.
- The parties initially operated based on a longstanding oral arrangement without a written contract; MDI referred tomography patients to CII, billed/collected/remitted payments to CII.
- In 1988 Dr. Adapon proposed acquisition of MRI equipment; the parties signed a Letter of Intent (LOI) prepared by MDI in November 1988, which included a non-compete provision (Section I, paragraph 4) and an arbitration clause (Section 11).
- From 1978 until 1997 the non-compete arrangement was observed by the parties; in 1997/1998 MDI purchased a 16-slice CT Scanner (initially purportedly for charity patients), later acquired a Siemens 128-slice CT Scanner in 2011 and an MRI Scanner in 2012, and began referring paying patients to its own hospital X-Ray/diagnostic departments.
- Dr. Adapon claimed MDI’s purchases and referrals breached the LOI’s non-compete clause, created an impression that CII’s services were inferior, and that MDI failed to pay for past services and reimburse damages to CII equipment incurred during hospital renovation.
- Dr. Adapon filed the Complaint in 2011 seeking enforcement of the non-compete clause and preliminary injunctive relief; the RTC denied preliminary injunctive relief and ordered arbitration pursuant to Section 11 of the LOI.
Letter of Intent: Terms Relevant to the Dispute
- Section I, paragraph 4 (non-compete provision): MDI and MMC shall not compete either directly or indirectly with CTCI and shall channel computer tomographical imaging and magnetic resonance imaging work to CTCI; Dr. Adapon shall not compete directly or indirectly with CTCI in those fields.
- Section 11 (arbitration clause): Provided that if parties cannot agree on specific details to be incorporated in the agreements, or on any matter arising out of the LOI, disputes shall be submitted to a three-member arbitration panel (one arbitrator selected by each party and a third mutually agreed upon); parties shall maintain the status quo pending arbitration and “abide by the ruling of the panel of arbitrators.”
- The LOI was signed in November 1988 by Dr. Adapon and by Drs. Manahan, Gustilo, and Fores for MDI.
Arbitration Proceedings and Tribunal Composition
- Parties voluntarily submitted to arbitration before the Philippine Dispute Resolution Center, Inc. (PDRCI), Taguig City.
- A three-member arbitral tribunal composed of:
- Former Chief Justice Renato S. Puno (mutually agreed arbitrator and chair);
- Retired Justice Dante O. Tinga (MDI’s nominee; he dissented in the Final Award);
- Atty. Jose A. Grapilon (former Integrated Bar of the Philippines President; Dr. Adapon’s nominee).
- Parties jointly drafted and signed the Terms of Reference governing arbitration; petitioner submitted a Statement of Claims and respondent a Statement of Defenses; both parties submitted Memorials after trial.
- The arbitral tribunal issued a Final Award dated May 8, 2015.
Final Award: Tribunal Findings and Disposition
- Jurisdiction: Tribunal rejected MDI’s claim of lack of jurisdiction, finding the parties had agreed to arbitrate under the LOI and pursuant to Sections 2 and 4 of Republic Act No. 876.
- Proper Forum: Tribunal held that because a derivative suit could include Dr. Adapon’s personal claims against MDI, the case fell within RTC jurisdiction.
- Enforceability of Non-Compete: The non-compete provision in the LOI was binding and enforceable; it could “stand alone” regardless of other provisional language in the LOI.
- Breach: MDI violated the non-compete agreement when it installed equipment in 1997/1998, 2011, and 2012 for paying patients of MMC.
- Prescription: Tribunal held claims for damages from 1998 to 2009 were barred by prescription but that claims for violations after 2009 were not prescribed under the “continuing violation theory” and equitable considerations.
- Additional Findings:
- The non-compete agreement was not an unlawful restraint of trade.
- No evidence showed Dr. Adapon breached the non-compete clause or had “unclean hands.”
- The case was both derivative and a direct action by Dr. Adapon, allowing personal claims.
- The award of damages was based on unrebutted evidence presented by Dr. Adapon.
- The doctrine of rebus sic stantibus (unforeseen events) did not apply.
- Dispositive portion ordered MDI to pay:
- Php 71,349,157.45 as actual and compensatory damages to Dr. Benjamin D. Adapon;
- Php 5,000,000.00 as moral damages to Dr. Adapon and CII;
- Php 2,000,000.00 as exemplary damages to Dr. Adapon and CII;
- Php 9,000,000.00 as attorney’s fees and litigation expenses to Dr. Adapon and CII;
- Counterclaims of MDI dismissed for lack of merit;
- Costs of suit to be paid jointly by the parties in accordance with PDRCI rules.
- Final Award authored by former Chief Justice Renato S. Puno and concurred in by Atty. Jose A. Grapilon.
Dissenting Opinion of Arbitrator Dante O. Tinga
- Justice (Ret.) Dante O. Tinga dissented, concluding both parties’ claims should be dismissed based on:
- Alleged lack of RTC jurisdiction over Dr. Adapon’s personal claims, and therefore the RTC’s lack of authority to refer the case to arbitration;
- The LOI and non-compete clause were not binding;
- Prescription barred the claims;
- Even if binding, the non-compete was an unreasonable restraint of trade, placing the parties in pari delicto;
- The catastrophic effect on MMC’s residency program supported application of rebus sic stantibus;
- Awards of damages lacked legal and factual bases.
Medical Doctors, Inc.’s Petition to Vacate: Grounds Raised
- MDI’s Petition to Vacate the arbitral award before the RTC alleged the arbitral tribunal exceeded its powers and raised specific points including:
- The non-compete clause cannot stand alone because:
- No evidence Drs. Manahan, Gustilo and Fores were authorized by MDI to enter the LOI.
- The LOI is merely an expression of intent, non-binding by nature.
- The non-compete clause lacked necessary terms and conditions and could not be read independently.
- The tribunal exceeded power in applying “continuing violation theory” and equitable considerations to avoid prescription for acts after 2009.
- The tribunal failed to apply rebus sic stantibus.
- The tribunal erred in rejecting the “clean hands” doctrine and in holding the non-compete was not an unreasonable restraint of trade.
- The tribunal exceeded power in awarding actual and compensatory damages to Dr. Adapon because the cause of action belonged to CII and the award was speculative.
- The tribunal awarded damages based on conjecture and speculation.
- The tribunal exceeded power in awarding moral damages, exemplary damages and costs of litigation to Dr. Adapon.
- The non-compete clause cannot stand alone because:
- MDI later raised additional jurisdictional arguments before the Court of Appeals, including that arbitration under the LOI was contingent on negotiations and thus inapplicable where no negotiations had taken place.
RTC Proceedings and Rationale for Confirmation
- RTC considered the LOI a valid and enforceable agreement and held that MDI failed to establish any of the grounds in Rule 11.4 of the Special ADR Rules for vacating a final award.
- RTC applied the principle that courts shall not disturb arbitral tribunals’ determinations of facts or interpretation of law, concluding the award of damages involved factual determinations beyond judici